Diabetes Topics
The On-Topic Netowork

Diabetes > Antagonist


Antagonist
Antagonist
Antagonist
Antagonist
Antagonist

The following information is about Antagonist.

Antagonist Defined

One agent that opposes or fights the action of another. For example, insulin lowers the level of glucose (sugar) in the blood, whereas glucagon raises it; therefore, insulin and glucagon are antagonists.

This definition is in context to Diabetes. See more contextual defintions for Antagonist.


Navigation: [ 1 2 Next ]

Theravance to Present at the Thomas Weisel Partners Healthcare Conference

Published August 21, 2008, 1:05 pm, PrimeNewswire via Yahoo! Finance

SOUTH SAN FRANCISCO, Calif., Aug. 21, 2008 -- Theravance, Inc. announced today that Rick E Winningham, Theravance's Chief Executive Officer, is scheduled to present at the Thomas Weisel Partners Healthcare Conference on Thursday, September 4, 2008, at 10:55 a.m.

Full Story


Prolonged Release Oxycodone/Naloxone Provides Effective Pain Relief And Reduces Opioid Induced Constipation In ...

Published August 20, 2008, 5:14 am, Medical News Today

Prolonged release oxycodone / naloxone is as effective as oxycodone alone in providing pain relief for patients with moderate to severe chronic pain while reducing the risk of opioid-induced constipation (OIC), according to new phase II and III data presented today at the 12th World Congress on Pain in Glasgow, Scotland.

Full Story


Plerixafor Treatment Improves Mobilization Of Cells In Donors During Bone Marrow Stem Cell Collection Procedures

Published August 19, 2008, 3:15 am, Medical News Today

In a study of 25 bone marrow donors, treatment with plerixafor, an antagonist able to disrupt a critical pathway associated with stem cell mobilization, was shown to mobilize cells faster than treatment with granular colony-stimulating factor (G-CSF), the current standard method used to collect bone marrow stem cells from healthy donors.

Full Story


Tobira Therapeutics Inc. Receives US Patent for TBR-652

Published August 18, 2008, 4:00 am, PR Newswire via Yahoo! Finance

Tobira Therapeutics Inc., a clinical stage biotechnology company committed to the research and product discovery against life-threatening and life-altering infectious diseases, today announced the issuance of Patent No. 7,371,772 B2 by the U.S.

Full Story


Potential New Treatments For Deadly Cancer Which Primarily Strikes Infants

Published August 18, 2008, 3:15 am, Medical News Today

Neuroblastoma is one of the most devastating diagnoses a child can receive. The cancer's victims average 2 years old when the disease is detected, most often by a parent feeling a lump in a child's abdomen.

Full Story


Experiments Could Lead To New Treatments For Neuroblastoma

Published August 17, 2008, 9:15 pm, Science Daily

Based on cell-culture and animal experiments, researchers believe they've found a critical weakness in neuroblastoma -- one that could lead to the development of a lifesaving therapy for victims of the cancer.

Full Story


How Stress Affects Blood Pressure

Published August 16, 2008, 3:51 am, BruDirect.com

By Rick Nauert, Ph.D. A new study investigates how the body regulates blood pressure in response to daily stress. “This research will give us information that allows us to identify what treatment is going to be effective in what individual by genotype, by obesity and other factors.

Full Story


EPIX Pharma initiates phase-2b right-heart catheter study of COPD drug

Published August 16, 2008, 3:43 am, PharmaBiz

EPIX Pharmaceuticals, Inc a biopharmaceutical company focused on discovering and developing novel therapeutics through the use of its proprietary and highly efficient in silico drug discovery platform, announced that it has initiated its phase-2b right-heart catheter study of PRX-08066 in patients with chronic obstructive pulmonary disease (COPD) and moderate-to-severe pulmonary hypertension ...

Full Story


Better Hypertension Treatment By Determining How The Body Regulates Blood Pressure In Response To Daily Stress

Published August 16, 2008, 3:16 am, Medical News Today

How the body regulates blood pressure in response to daily stress is the focus of a study geared toward helping people whose pressure is out of control. "Research shows that two-thirds of patients' high blood pressure is not controlled despite the best efforts of their doctors. That is terrible," says Dr.

Full Story


Experiments could lead to new treatments for neuroblastoma

Published August 15, 2008, 11:53 pm, PhysOrg

Neuroblastoma is one of the most devastating diagnoses a child can receive. The cancer's victims average 2 years old when the disease is detected, most often by a parent feeling a lump in a child's abdomen. By then, the disease has often reached an advanced stage, and advanced neuroblastoma kills more than 50 percent of the children in whom it develops, despite aggressive treatment with surgery, ...

Full Story


Navigation: [ 1 2 Next ]

Are you looking for additional Diabetes > Antagonist news? Try our new "Antagonist News Focus" area.

Off-site Antagonist Links, User Submitted

The following links have been collected through user bookmark submission in the Antagonist category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Thu Jul 24

Sat May 31

Thu May 8

Mon Apr 28

Thu Mar 27

Wed Mar 19

Tue Feb 19

Mon Feb 18

Tue Feb 12

If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Antagonist. If you would like to find related tags we recommend Tag Patterns > Antagonist

Off-site Antagonist Research Links

If you still need additional information on Antagonist then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Diabetes

If you know the Diabetes Term Name use the links below to quickly jump to your desired focus.



Bookmark Us

The On Topic Network

This website is part of The On Topic Network.

Thank You

Diabetes.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.

Best Viewed With

License

Creative Commons License This work is licensed under Creative Commons.




Powered by Odin Assemble 2.5a